# Circulating Tumor DNA Exposure in Peripheral Blood

> **NCT03517332** · — · UNKNOWN · sponsor: **Quantgene Inc.** · enrollment: 10000 (estimated)

## Conditions studied

- Colorectal Cancer
- Pancreatic Adenocarcinoma
- Gastric Cancer
- Hepatocellular Carcinoma
- Non-small Cell Lung Cancer
- Bladder Cancer
- Melanoma
- Ovarian Cancer
- Adrenocortical Cancer
- Breast Cancer
- Other Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03517332
- **Lead sponsor:** Quantgene Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03517332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03517332, "Circulating Tumor DNA Exposure in Peripheral Blood". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03517332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*